MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York funding

A Humanized Monoclonal Fsh Blocking Antibody For Alzheimer's Disease - Project Summary Alzheimer’s Disease (ad) Stands…

$10.6M

ShareLinkedIn ↗Email
Funder
Department of Health and Human Services
Amount
$10.6M
Recipient
Icahn School Of Medicine At Mount Sinai
Deadline
Through August 31, 2027

Purpose

Department of Health and Human Services awarded $10.6M to Icahn School Of Medicine At Mount Sinai for A humanized monoclonal fsh blocking antibody for alzheimer's disease - project summary alzheimer’s disease (ad) stands out as notable in not having a cure among many diseases that affect elderly men and women––in essence, creating an urgent need for a new therapy. it is also unclear why menopausal women have a preponderance of ad, and, while declining estrogen bas been implicated, there is clear clinical correlation with rising levels of follicle stimulating hormone (fsh). we have identified fsh as a target for several aging disorders––osteoporosis, obesity, hypercholesteremia––and now, ad. inhibiting the action of fsh using blocking antibodies reduces body fat, increases bone mass,…

federalusaspendinggranthealthny

Official source ↗

Free account

Create a free account

Track New York funding and save searches across the Network. Free. No card required.

Want to reach the funders and organizations active in your market? Build your Market Network Strategic Plan →